TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314507. A total of 28 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $162,000 | – | 90,838 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 90,838 | $162,000 | 0.11% |
| Winning Points Advisors, LLC | 13,549 | $24,000 | 0.02% |
| A.R.T. Advisors, LLC | 26,312 | $47,000 | 0.00% |
| Blume Capital Management, Inc. | 425 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 473,164 | $842,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 35 | $0 | 0.00% |
| UBS Group AG | 7,791 | $14,000 | 0.00% |
| MARINO, STRAM & ASSOCIATES LLC | 61 | $0 | 0.00% |
| Advisor Group, Inc. | 350 | $1,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 87 | $0 | 0.00% |